These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16621116

  • 1. Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.
    Karagüzel G, Satilmiş A, Akçurin S, Bircan I.
    Diabetes Res Clin Pract; 2006 Oct; 74(1):15-20. PubMed ID: 16621116
    [Abstract] [Full Text] [Related]

  • 2. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [Abstract] [Full Text] [Related]

  • 3. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.
    Hamann A, Matthaei S, Rosak C, Silvestre L, HOE901/4007 Study Group.
    Diabetes Care; 2003 Jun; 26(6):1738-44. PubMed ID: 12766103
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
    Fulcher GR, Gilbert RE, Yue DK.
    Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [Abstract] [Full Text] [Related]

  • 9. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [Abstract] [Full Text] [Related]

  • 10. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.
    Fritsche A, Schweitzer MA, Häring HU, 4001 Study Group.
    Ann Intern Med; 2003 Jun 17; 138(12):952-9. PubMed ID: 12809451
    [Abstract] [Full Text] [Related]

  • 11. [Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy].
    Pesić M, Zivić S, Radenković S, Velojić M, Dimić D, Antić S.
    Vojnosanit Pregl; 2007 Apr 17; 64(4):247-52. PubMed ID: 17580534
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.
    Albright ES, Desmond R, Bell DS.
    Diabetes Care; 2004 Feb 17; 27(2):632-3. PubMed ID: 14747268
    [No Abstract] [Full Text] [Related]

  • 13. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.
    Home PD, Rosskamp R, Forjanic-Klapproth J, Dressler A, European Insulin Glargine Study Group.
    Diabetes Metab Res Rev; 2005 Feb 17; 21(6):545-53. PubMed ID: 16021649
    [Abstract] [Full Text] [Related]

  • 14. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.
    Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL, Dunger DB.
    Diabetes Care; 2003 Mar 17; 26(3):799-804. PubMed ID: 12610040
    [Abstract] [Full Text] [Related]

  • 15. A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study.
    Fonseca V, Bell DS, Berger S, Thomson S, Mecca TE.
    Am J Med Sci; 2004 Nov 17; 328(5):274-80. PubMed ID: 15545844
    [Abstract] [Full Text] [Related]

  • 16. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
    Chatterjee S, Jarvis-Kay J, Rengarajan T, Lawrence IG, McNally PG, Davies MJ.
    Diabetes Res Clin Pract; 2007 Aug 17; 77(2):215-22. PubMed ID: 17141354
    [Abstract] [Full Text] [Related]

  • 17. Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.
    Sargin H, Sargin M, Altuntaş Y, Sengül AM, Orbay E, Seber S, Uçak S, Yayla A.
    Diabetes Res Clin Pract; 2003 Nov 17; 62(2):79-86. PubMed ID: 14581144
    [Abstract] [Full Text] [Related]

  • 18. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.
    Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB.
    Diabet Med; 2004 Nov 17; 21(11):1213-20. PubMed ID: 15498088
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
    Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.
    Endocr J; 2007 Dec 17; 54(6):975-83. PubMed ID: 18000343
    [Abstract] [Full Text] [Related]

  • 20. Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes.
    Wiesli P, Krayenbühl P, Uthoff H, Seifert B, Schmid C.
    Diabetologia; 2009 Sep 17; 52(9):1816-9. PubMed ID: 19565212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.